Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics cash
Cash and short-term investments held at the end of each period.
Scinai Immunotherapeutics's cash was $2.65M at Jun 30, 2026. For fiscal 2025 it was $1.66M, down 20.7% from the year before. The highest annual figure on record is $22.54M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66M | -20.7% |
| FY2024 | Dec 31, 2024 | $2.10M | -57.0% |
| FY2023 | Dec 31, 2023 | $4.87M | -65.7% |
| FY2022 | Dec 31, 2022 | $14.22M | -18.9% |
| FY2021 | Dec 31, 2021 | $17.52M | +469.3% |
| FY2020 | Dec 31, 2020 | $3.08M | -86.3% |
| FY2019 | Dec 31, 2019 | $22.54M | +9.5% |
| FY2017 | Dec 31, 2017 | $20.59M | +354.5% |
| FY2016 | Dec 31, 2016 | $4.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.65M | -13.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.66M | -65.9% |
| Q2 FY2025 | Jun 30, 2025 | $989.00K | -1.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.10M | -72.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.08M | -71.5% |
| Q4 FY2023 | Dec 31, 2023 | $4.87M | -65.7% |
| Q3 FY2023 | Sep 19, 2023 | $1.00M | -91.1% |
| Q2 FY2023 | Jun 30, 2023 | $7.51M | -51.2% |
| Q1 FY2023 | Mar 31, 2023 | $10.80M | -38.4% |
| Q4 FY2022 | Dec 31, 2022 | $14.22M | +32.4% |
| Q2 FY2022 | Jun 30, 2022 | $11.29M | +266.8% |
| Q1 FY2022 | Mar 31, 2022 | $15.39M | -31.7% |
| Q4 FY2021 | Dec 31, 2021 | $17.52M | -14.9% |
| Q3 FY2021 | Sep 30, 2021 | $10.74M | +137.0% |
| Q4 FY2020 | Dec 31, 2020 | $3.08M | – |
| Q4 FY2019 | Dec 31, 2019 | $22.54M | – |
| Q4 FY2017 | Dec 31, 2017 | $20.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.53M | – |
See a number that looks wrong?